Emcure Pharmaceuticals Limited (NSE:EMCURE)

Market Cap	203.43B
Revenue (ttm)	75.51B
Net Income (ttm)	6.08B
Shares Out	189.48M
EPS (ttm)	32.85
PE Ratio	32.68
Forward PE	24.20
Dividend	n/a
Ex-Dividend Date	n/a

Volume	119,219
Average Volume	78,191
Open	1,061.90
Previous Close	1,060.40
Day's Range	1,047.00 - 1,092.00
52-Week Range	889.00 - 1,580.00
Beta	n/a
RSI	57.73
Earnings Date	May 27, 2025

About Emcure Pharmaceuticals

Emcure Pharmaceuticals Limited engages in the developing, manufacturing, and marketing pharmaceutical products worldwide. It offers products in various therapeutic areas, such as gynecology, cardiovascular, anti-infectives, HIV antivirals, respiratory, gastrointestinal, pain and analgesics, blood related, oncology/anti-neoplastics, anti-diabetic, hormones, neurology/central nervous system, dermatology, and other areas, as well as vitamins, minerals, and nutrients. The company also develops products across various platforms, including chiral mol...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1981
• Employees: 10,852
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: EMCURE

Financial Performance

In 2023, Emcure Pharmaceuticals's revenue was 66.58 billion, an increase of 11.23% compared to the previous year's 59.86 billion. Earnings were 4.98 billion, a decrease of -6.36%.